I. J. Owens

The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en.

J. McKimm-Breschkin, T. Blick, A. Sahasrabudhe, 1998, Virology.

Chemoprophylaxis of Influenza A Virus Infections, with Single Doses of Zanamivir, Demonstrates that Zanamivir Is Cleared Slowly from the Respiratory Tract

Lisa C. Crossman, R. Fenton, S. Parry, 1999, Antimicrobial Agents and Chemotherapy.

Characterization of 2 influenza A(H3N2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the hemagglutinin gene.

G. Boivin, Yacine Abed, A. Bourgault, 2002, The Journal of infectious diseases.

Zanamivir Susceptibility Monitoring and Characterization of Influenza Virus Clinical Isolates Obtained during Phase II Clinical Efficacy Studies

A. Osterhaus, G. Rimmelzwaan, E. Claas, 2000, Antimicrobial Agents and Chemotherapy.

Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza.

Stephanie Hamilton, Rachel Cameron, Simon J F Macdonald, 2005, Journal of medicinal chemistry.

Potent and Long-Acting Dimeric Inhibitors of Influenza Virus Neuraminidase Are Effective at a Once-Weekly Dosing Regimen

H. T. Jones, Andy M Mason, S. Tucker, 2004, Antimicrobial Agents and Chemotherapy.

FK962 and donepezil act synergistically to improve cognition in rats: Potential as an add-on therapy for Alzheimer's disease

L. Saksida, T. Bussey, A. Bansal, 2011, Pharmacology Biochemistry and Behavior.